Navigation Links
BioLineRx Presents Data From Successful Phase I Trial for BL-1020,in Schizophrenia at American Psychiatric Association Conference

m the Department of Chemistry, Bar-Ilan University; and Ada Rephaeli, Ph.D., Professor Abraham Weizman, MD, and Irit Gil-Ad, Ph.D. from the Sackler Faculty of Medicine, Tel Aviv University.

About BioLineRx

BioLineRx, a clinical stage drug development company traded on the Tel Aviv Stock Exchange (TASE:BLRX), is dedicated to building a robust pipeline of promising therapeutics for unmet medical needs. The Company's leading programs are for schizophrenia and treatment of damaged heart tissue post-myocardial infarction. Additional products under development include compounds for the treatment of cancer and CNS, cardiovascular, metabolic, infectious and autoimmune diseases.

BioLineRx advances projects from early stage discovery and lead generation to advanced clinical trials, regulatory approval and marketing. Partnering with researchers, universities and biotech companies to further the commercialization of promising compounds, BioLineRx seeks to enrich the pipeline of large pharmaceutical companies seeking their next blockbuster drugs. The Company was founded in 2003 by leaders in the Israeli life science arena including Teva Pharmaceuticals Ltd, Giza, Pitango, Hadasit and the Jerusalem Development Authority. For more information, please visit www.biolinerx.com.

This press release contains "forward-looking statements." These statements include words like "may," "expects," "believes," "scheduled" and "intends," and describe opinions about future events. These forward-looking statements involve known and unknown risks and uncertainties that may cause the actual results, performance or achievements of BioLineRx to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements.

Contact

BioLineRx Ltd.
Yuri Shoshan, +972-2-548-9100
VP Finance and Corporate Development
yuri@biolinerx.com
'"/>




Page: 1 2 3 4

Related medicine technology :

1. BioLineRx Presents Phase I Clinical Data of BL-1020 at Upcoming Clinical Conferences
2. BioLineRx Presents Data on BL-1040 at Cardiovascular Revascularization Therapies Conference Demonstrating Potential to Reduce Deterioration of Infarcted Heart Tissue and Maintain Functionality
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
5. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
6. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
7. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
8. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
9. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
10. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
11. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
Post Your Comments:
(Date:7/28/2014)... , July 28, 2014   Stone ... settlement of off-label marketing and fraud claims between ... Vascular Solutions, Inc. ("VSI").  The settlement covers fraud ... devices for endovenous laser ablation of varicose veins ... a firm with a history of representing whistleblowers ...
(Date:7/28/2014)... 28, 2014  Surgical Theater, LLC announced today ... Business Advisory Board. New members include Ori ... Business Development and New Technologies for Given Imaging ... Senior Vice President and General Manager of Philips ... flight simulation technology to brain surgery and has ...
(Date:7/28/2014)... 2014 Southern Research Institute today announced ... and CEO of Southern Research Institute, has been ... for the 2014-2015 term.  The inauguration took place ... in Chicago with attendees ... The Controlled Release Society is an international, interdisciplinary, ...
Breaking Medicine Technology:Stone & Magnanini LLP Announces $520,000 Department of Justice False Claims Act Settlement With Vascular Solutions, Inc. 2Stone & Magnanini LLP Announces $520,000 Department of Justice False Claims Act Settlement With Vascular Solutions, Inc. 3Surgical Theater Names Former Given Imaging Ltd. and Philips Healthcare Executives to Business Advisory Board 2Surgical Theater Names Former Given Imaging Ltd. and Philips Healthcare Executives to Business Advisory Board 3Surgical Theater Names Former Given Imaging Ltd. and Philips Healthcare Executives to Business Advisory Board 4Surgical Theater Names Former Given Imaging Ltd. and Philips Healthcare Executives to Business Advisory Board 5Arthur J. Tipton, Ph.D., Named President of Controlled Release Society 2Arthur J. Tipton, Ph.D., Named President of Controlled Release Society 3
... NEW YORK , Aug. 2 As eyewear is increasingly ... a series of new television commercials for those who have lost sight of ... deliver. , , , ... reminder: "Unless the glasses can perform miracles, don,t pay more than you have ...
... 2 ORBIS International is pleased to announce the appointment of Dr. ... Board of Directors. , , , ... Dr. Robert Walters has been an active member of ... the Board of Directors of ORBIS UK since 2003 and Chairman of ...
Cached Medicine Technology:For Eyes Optical Takes Man to Places He's Never Been Before in Humorous New TV Campaign 2For Eyes Optical Takes Man to Places He's Never Been Before in Humorous New TV Campaign 3Robert F. Walters Appointed Chairman of the Board of Directors of ORBIS International 2Robert F. Walters Appointed Chairman of the Board of Directors of ORBIS International 3
(Date:7/28/2014)... A lush green lawn offers the perfect setting ... the summer heat, lack of rain, foot traffic, and insects ... unhealthy. The Grounds Guys recommends these suggestions for nurturing your ... a week and set the height on the lawn mower ... roots from heat and allows roots to retain water and ...
(Date:7/28/2014)... 28, 2014 Quincy Bioscience, makers of ... pleased to announce the release of the fourth edition ... and co-founder Mark Underwood. , The Brain Health Guide ... useful techniques for readers to improve memory and promote ... conclusion, The Brain Health Guide provides ways to help ...
(Date:7/28/2014)... -- Elementary school students seem to be satisfied with the ... new study of school officials. , , New meal standards ... into effect in the fall of 2012. At the time, ... throw away most of their food. But the new study ... case. , , "The updated meals standards are resulting in ...
(Date:7/28/2014)... Nashville, TN (PRWEB) July 28, 2014 ... successful Operation Military June . Renowned LASIK ... Military June" to provide significant funds and public ... active and retired military personnel and their families. ... we will proudly give nearly $5,000 to a ...
(Date:7/28/2014)... Maureen Salamon HealthDay Reporter ... Infants and children who are at risk of contracting ... against the infection, according to updated recommendations from the ... And routine vaccinations for the potentially deadly infection should ... of Pediatrics says. In its first statement on ...
Breaking Medicine News(10 mins):Health News:Nurturing Lawns in the Summer Heat: The Grounds Guys® Offers Tips on Caring for Lawns This Summer 2Health News:Quincy Bioscience Launches the Fourth Edition of The Brain Health Guide 2Health News:Healthy School Lunches Get Thumbs Up From Students 2Health News:Shofner Vision Center’s “Operation Military June” Provided Funds For Local Not-For-Profit Organizations Supporting Military And Their Families 2Health News:Shofner Vision Center’s “Operation Military June” Provided Funds For Local Not-For-Profit Organizations Supporting Military And Their Families 3Health News:Doctors Urge Meningitis Shots for Vulnerable Infants, Children 2Health News:Doctors Urge Meningitis Shots for Vulnerable Infants, Children 3
... Dental Program Targets Elementary School Children , ... St. ... expands its statewide preventive dental program to St. Cloud Area School ... help improve the oral health of low-income and uninsured children. Smiles ...
... Off This Month, Urging People Across the Country ... 24, 2009 WILMINGTON, Del., March 24 ... the launch of the 2009 US AGAINST ATHERO ... multisensory, motion simulator that helps people visualize atherosclerosis ...
... Patients on What to Expect From Medical ProceduresNASHVILLE, ... Booths #11 & 12 -- GetWellNetwork, Inc. ... (IPC) solutions, and KidsHealth , the largest ... two new content suites to their pediatric patient ...
... with type 2 diabetes are significantly more at risk of losing ... White Europeans with the same condition. , A UK study ... to the retina) is more prevalent in South Asians and occurs ... The study, published in the latest issue of Diabetes Care ...
... Available for Florida Providers JACKSONVILLE, Fla., ... health information network, announced today an expanded partnership ... providing affordable health care to families and individuals. ... access to Molina Healthcare via the Availity secure ...
... Va., March 24 The National Hospice Foundation will hold ... - on Friday, April 24, 2009, at the Omni Shoreham ... advanced hospice and palliative care in an extraordinary way and ... Chris Matthews, host of MSNBC,s Hardball with Chris Matthews ...
Cached Medicine News:Health News:Smiles Across Minnesota Expands Program to St. Cloud 2Health News:Smiles Across Minnesota Expands Program to St. Cloud 3Health News:Smiles Across Minnesota Expands Program to St. Cloud 4Health News:Video: Astrazeneca Calls on All Americans to Join US AGAINST ATHERO to Fight the Nation's Number One Killer 2Health News:Video: Astrazeneca Calls on All Americans to Join US AGAINST ATHERO to Fight the Nation's Number One Killer 3Health News:Video: Astrazeneca Calls on All Americans to Join US AGAINST ATHERO to Fight the Nation's Number One Killer 4Health News:GetWellNetwork and KidsHealth(R) Launch New Interactive Patient Education Content for Pediatric Patients and Their Families 2Health News:GetWellNetwork and KidsHealth(R) Launch New Interactive Patient Education Content for Pediatric Patients and Their Families 3Health News:GetWellNetwork and KidsHealth(R) Launch New Interactive Patient Education Content for Pediatric Patients and Their Families 4Health News:South Asians with diabetes more likely to lose their eyesight earlier than white Europeans 2Health News:Availity Expands Partnership with Molina Healthcare 2Health News:National Hospice Foundation Gala to be a Sparkling Celebration 2
... The menu-driven Vapro osmometer determines osmolality ... natural equilibrium. ,What you don't get are ... particles, or other conditions that interfere with ... percent in the clinical range) Vapro osmometer ...
... Colloid Osmometer. Rapid measurement of colloid ... of edema onset in clinical situations. ... and reference chambers to simulate the ... in the establishment of osmotic pressure ...
... Automated Cortisol assay ... increased laboratory workflow, Excellent correlation ... assay provides confidence,in assay performance, ... Serum Reference Panels delivers assurance ...
Quantitative determination of cortisol levels in serum and urine. Cross-reactivity with dexamethasone: 0.2% (suppression test).Time to first result: 30 minutes....
Medicine Products: